UK markets closed

Astellas Pharma Inc. (ALPMF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
9.75+0.58 (+6.32%)
At close: 10:53AM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts1156
Avg. Estimate0.020.190.20.48
Low estimate0.020.190.020.4
High estimate0.020.190.330.56
Year ago EPS-0.180.120.380.2
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts3166
Avg. Estimate2.48M2.54M10.22M10.94M
Low estimate2.42M2.54M10.12M10.28M
High estimate2.57M2.54M10.3M11.39M
Year ago sales2.47MN/A10.58M10.22M
Sales growth (year/est)0.50%N/A-3.40%7.00%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.030.210.20.12
Actual EPS-0.180.12-0.010.07
Difference-0.15-0.09-0.21-0.05
Surprise %-500.00%-42.90%-105.00%-41.70%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate0.020.190.20.48
7 days ago0.020.190.260.53
30 days ago0.020.190.330.64
60 days ago0.020.190.380.69
90 days ago0.090.20.380.73
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 days1N/AN/AN/A
Up last 30 days1N/AN/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 days1N/A22
Growth estimatesALPMFIndustrySector(s)S&P 500
Current qtr.111.10%N/AN/AN/A
Next qtr.58.30%N/AN/AN/A
Current year-47.40%N/AN/AN/A
Next year140.00%N/AN/AN/A
Next 5 years (per annum)0.11%N/AN/AN/A
Past 5 years (per annum)-6.56%N/AN/AN/A